DS Logo

Information intended for healthcare professionals only. This implementation checklist has been commissioned and funded by Daiichi Sankyo UK and developed in partnership with Guidelines in Practice. See below for full disclaimer.

View LIXIANA (edoxaban) prescribing and adverse event reporting information

Download the checklist

If the PDF does not load within 5 seconds, please refresh the page

 

This implementation checklist has been commissioned and funded by Daiichi Sankyo UK and developed in partnership with Guidelines in Practice. Daiichi Sankyo UK suggested the topic and carried out full medical approval to ensure compliance with regulations. The sponsorship fee included an honorarium for the author.

NICE was not involved in the development of this checklist, and this checklist does not imply NICE endorsement of the sponsoring company’s products. No part of this publication may be reproduced in any form without the permission of the publisher.

EDX/21/0536

Date of preparation: July 2021